Technology Talks
Home of Technology Talks, the Afon Technology podcast.
- Blood Glucose Watch
- Non-Invasive Glucose Monitor
- Watch For Diabetes
Technology Talks
All about Afon
Launched in July 2025, Technology Talks is our podcast all about Afon Technology, Glucowear™, and our mission to bring the world’s first, wrist worn, non-invasive blood glucose indicator to market.
Delving into a variety of related topics, you can listen to Technology Talks through Spotify. New episodes are released each month.
Timeline in 2026
Episode 1, first released 31.07.2025
In the first episode of ‘Technology Talks’, Sabih Chaudhry, CEO of Afon Technology, and Oliver Jelley discuss the 2026 timeline for Glucowear™.
Glucowear™ Is the world’s first non-invasive, real-time and continuous blood glucose indicator. The device is worn on the inside of the wrist with or without a watch, and it feeds back to the user’s chosen smart device to display blood glucose data.
Unlike the current continuous glucose monitoring devices, it will measure blood glucose levels in real-time without the need to penetrate the skin at all, making it easier to manage the condition, reducing the risk of diabetes-related complications such as heart attack, stroke, blindness, kidney failure and limb amputations.
History
Episode 2, first released 26.09.2025
Afon technology is developing Glucowear™ – the world’s first non-invasive, real-time and continuous blood glucose sensor. The device is worn on the inside of the wrist with or without a watch, and it feeds back to the user’s chosen smart device to display blood glucose data.
Unlike the current continuous glucose monitoring devices, it will measure blood glucose levels in real-time without the need to penetrate the skin at all, making it easier to manage the condition, reducing the risk of diabetes-related complications such as heart attack, stroke, blindness, kidney failure and limb amputations.
Accuracy of MARD data
Episode 3, first released 13.11.2025
Afon technology is developing Glucowear™ – the world’s first non-invasive, real-time and continuous blood glucose sensor. The device is worn on the inside of the wrist with or without a watch, and it feeds back to the user’s chosen smart device to display blood glucose data.
Unlike the current continuous glucose monitoring devices, it will measure blood glucose levels in real-time without the need to penetrate the skin at all, making it easier to manage the condition, reducing the risk of diabetes-related complications such as heart attack, stroke, blindness, kidney failure and limb amputations.
Leading the way in non-invasive continuous glucose monitoring
Episode 4, first released 16.12.2025
Sign up to receive email updates on our progress!
All about Afon Technology
Founded by Dr Sabih Chaudhry Afon Technology is a medical device business developing the non-invasive, continuous blood glucose monitor Glucowear™. Supporting Dr Sabih Chaudhry is a highly experienced, multidisciplinary team of clinical experts, engineers, and life sciences professionals.
Designed to transform life for people living with diabetes, Glucowear™ delivers clinically accurate glucose readings without the need for needles or skin sensors.
Afon’ Technology’s commitment to innovation has been widely recognised. The company has won multiple national and international awards across STEM, innovation, health, and product design categories, including repeat wins at the Junkosha Technology Innovator Awards.
Frequently Asked Questions
This podcast series explores the key developments of Afon Technology’s device Glucowear™, the world’s first non-invasive blood glucose monitoring device, which is tipped to transform the lives of those with diabetes.
Episodes are released once a month.
The podcast Technology Talks, All about Afon launched in July 2025.
Yes you can, simply email info@afontechnology.com with your suggestions.
Yes, we’ll be discussing a range of topics around Glucowear™. Check the episode descriptions for details on the content.
You can listen to Technology Talks on Spotify.
Yes you can you can follow us and subscribe on Spotify.
